|
|
|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
|
Z-2681-2014 - The Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN), performed using the sample-to-result Verigene System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous det...
|
2
|
09/23/2014
|
FEI # 3006028115 Nanosphere, Inc.
|
|
Z-2682-2014 - The Verigene Clostridium difficile Nucleic Acid Test (CDF) is a qualitative, multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of ...
|
2
|
09/23/2014
|
FEI # 3006028115 Nanosphere, Inc.
|
|
Z-2685-2014 - The Verigene Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria and genetic virulence marke...
|
2
|
09/23/2014
|
FEI # 3006028115 Nanosphere, Inc.
|
|
Z-2684-2014 - The Verigene Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory viru...
|
2
|
09/23/2014
|
FEI # 3006028115 Nanosphere, Inc.
|
|
Z-2683-2014 - The Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-UP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous dete...
|
2
|
09/23/2014
|
FEI # 3006028115 Nanosphere, Inc.
|